Generated by AI
CollPlant Biotechnologies Ltd. is a technology company focused on photonic computing and advanced biotechnology. Through its LightSolver subsidiary, the company develops all-optical computing architectures based on interacting lasers and its proprietary Laser Processing Unit, designed to address demanding computational workloads across artificial intelligence, aerospace, financial engineering, and high-performance computing. These systems use light to perform computational operations, positioning the business within emerging markets for energy-conscious, high-performance processing. CollPlant also retains biotechnology activities centered on plant-derived recombinant human collagen and specialized bio-ink materials. These products support applications in three-dimensional bioprinting of tissues and organs, as well as medical aesthetics. The company therefore spans two distinct technology domains: deep-tech computing infrastructure and biomaterials for healthcare and life-science applications. Headquartered in Rehovot, Israel, CollPlant serves as a market participant at the intersection of photonics, computing, regenerative medicine, medical aesthetics, and biofabrication, with operations addressing both industrial technology users and specialized biomedical markets.
WebsiteWeizmann Science Park
Rehovot, 7670104
Israel
The latest articles about CLGN.
Detailed price information for Collplant Biotechnologies Ltd ADR (CLGN-Q) from The Globe and Mail including charting and trades.
Summary of Oct 30's posts. Generated by AI.
Summary of Sep 1's posts. Generated by AI.
Summary of Oct 30's posts. Generated by AI.
Investors talking about CLGN also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.